Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort
- Resource Type
- Source
- Cancer Immunology, Immunotherapy. 69:1177-1187
- Subject
Oncology Cancer Research medicine.medical_specialty business.industry Immunology MEDLINE Exploratory analysis medicine.disease 03 medical and health sciences 0302 clinical medicine Immune system Internal medicine Cohort Immunology and Allergy Medicine Nivolumab business Lung cancer Adverse effect 030215 immunology Pneumonitis - Language
- ISSN
- 1432-0851
0340-7004